Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04789408
Title Study Evaluating the Safety of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide + Fludarabine + KITE-222

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.